<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="151">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05159180</url>
  </required_header>
  <id_info>
    <org_study_id>IIBSP-IMS-2021-74</org_study_id>
    <nct_id>NCT05159180</nct_id>
  </id_info>
  <brief_title>Development of a New Impedance Mapping System for Ablation of Atrial Arrhythmias in Patients</brief_title>
  <official_title>Desarrollo de un Nuevo Sistema de Mapeo de Impedancia Para la ablación de Las Arritmias Auriculares en Pacientes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Precise identification of the atrial fibrosis is essential for successful catheter ablation&#xD;
      of atrial arrhythmias in patients with atrial fibrillation. Voltage mapping of endocardial&#xD;
      electrograms is currently used to delineate the anatomical substrate, but this is influenced&#xD;
      by the direction of the activation wave front and is limited by the patient-specific&#xD;
      thresholds. Mapping of local myocardial electrical impedance may overcome these limitations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical series: Patients with atrial arrythmias undergoing catheter ablation of these will&#xD;
      be submitted to mapping of both voltage and tissue impedance. Likewise, the accuracy of the&#xD;
      two maps identifying the extent of the substrate will be assesssed by gadolinium imaging. The&#xD;
      impedance system is already constructed and certified for clinical research use.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 13, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">July 31, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparative detection of atrial scar by voltage mapping</measure>
    <time_frame>30 minutes</time_frame>
    <description>Voltage will be measured at different sites of the atrial scar and healthy tissue.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparative detection of atrial scar by impedance mapping</measure>
    <time_frame>30 minutes</time_frame>
    <description>Myocardial local impedance spectroscopy will be measured at different sites of the atrial scar and healthy tissue.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Comparative detection of atrial scar by gadolinium enhanced MR imaging</measure>
    <time_frame>30 minutes</time_frame>
    <description>Intensity of gadolinium will be measured at different sites of the infarct scar and healthy tissue</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Atrial Fibrillation and Flutter</condition>
  <condition>Atrial Arrhythmia</condition>
  <condition>Atrial Fibrillation Recurrent</condition>
  <arm_group>
    <arm_group_label>patients with atrial arrhythmias undergoing catheter ablation of these</arm_group_label>
    <description>Patients will be submitted to mapping of both voltage and tissue impedance. The accuracy of the two maps identifying the extent and transmurality of the infarction will be assesssed by gadolinium imaging.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cardioz mapping</intervention_name>
    <description>Patients will be submitted to mapping of both voltage and tissue impedance.</description>
    <arm_group_label>patients with atrial arrhythmias undergoing catheter ablation of these</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with atrial arrhythmias undergoing catheter ablation&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age between 18 and 85 years.&#xD;
&#xD;
          -  That they understand and sign the informed consent.&#xD;
&#xD;
          -  That they do not present any contraindication.- Pass the exploration and tests prior&#xD;
             to bioimpedance measurements.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Age outside the range described in the inclusion criteria.&#xD;
&#xD;
          -  Subjects who present any type of complication during the procedure.&#xD;
&#xD;
          -  Pregnancy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jose M Guerra, MD, PhD</last_name>
    <phone>+34935537058</phone>
    <email>jguerra@santpau.cat</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gerard Amorós, MSc, PhD</last_name>
    <email>gamorosf@santpau.cat</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital de la Santa Creu i Sant Pau</name>
      <address>
        <city>Barcelona</city>
        <zip>08026</zip>
        <country>Spain</country>
      </address>
    </facility>
    <contact>
      <last_name>Laia Angli</last_name>
      <phone>+34935537058</phone>
      <email>langli@santpau.cat</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Amorós-Figueras G, Jorge E, García-Sánchez T, Bragós R, Rosell-Ferrer J, Cinca J. Recognition of Fibrotic Infarct Density by the Pattern of Local Systolic-Diastolic Myocardial Electrical Impedance. Front Physiol. 2016 Aug 31;7:389. doi: 10.3389/fphys.2016.00389. eCollection 2016.</citation>
    <PMID>27630580</PMID>
  </results_reference>
  <results_reference>
    <citation>Amorós-Figueras G, Jorge E, Alonso-Martin C, Traver D, Ballesta M, Bragós R, Rosell-Ferrer J, Cinca J. Endocardial infarct scar recognition by myocardial electrical impedance is not influenced by changes in cardiac activation sequence. Heart Rhythm. 2018 Apr;15(4):589-596. doi: 10.1016/j.hrthm.2017.11.031. Epub 2017 Dec 27.</citation>
    <PMID>29197656</PMID>
  </results_reference>
  <results_reference>
    <citation>Jorge E, Amorós-Figueras G, García-Sánchez T, Bragós R, Rosell-Ferrer J, Cinca J. Early detection of acute transmural myocardial ischemia by the phasic systolic-diastolic changes of local tissue electrical impedance. Am J Physiol Heart Circ Physiol. 2016 Feb 1;310(3):H436-43. doi: 10.1152/ajpheart.00754.2015. Epub 2015 Nov 25.</citation>
    <PMID>26608340</PMID>
  </results_reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>December 3, 2021</study_first_submitted>
  <study_first_submitted_qc>December 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 16, 2021</study_first_posted>
  <last_update_submitted>December 3, 2021</last_update_submitted>
  <last_update_submitted_qc>December 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>impedance spectroscopy</keyword>
  <keyword>phase angle</keyword>
  <keyword>impedance magnitude</keyword>
  <keyword>Electroanatomical mapping</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

